As of 2024-12-12, the EV/EBITDA ratio of AxoGen Inc (AXGN) is -824.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AxoGen's latest enterprise value is 682.62 mil USD. AxoGen's TTM EBITDA according to its financial statements is -0.83 mil USD. Dividing these 2 quantities gives us the above AxoGen EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 17.9x | 16.9x |
| Forward P/E multiples | 18.5x - 20.8x | 20.2x |
| Fair Price | (1.00) - (0.99) | (1.00) |
| Upside | -106.7% - -106.6% | -106.7% |
| Date | EV/EBITDA |
| 2024-12-10 | -823.36 |
| 2024-12-09 | -814.32 |
| 2024-12-06 | -827.08 |
| 2024-12-05 | -814.32 |
| 2024-12-04 | -822.82 |
| 2024-12-03 | -802.09 |
| 2024-12-02 | -808.47 |
| 2024-11-29 | -773.39 |
| 2024-11-27 | -782.43 |
| 2024-11-26 | -757.98 |
| 2024-11-25 | -750.54 |
| 2024-11-22 | -743.63 |
| 2024-11-21 | -730.87 |
| 2024-11-20 | -720.24 |
| 2024-11-19 | -712.27 |
| 2024-11-18 | -714.93 |
| 2024-11-15 | -706.42 |
| 2024-11-14 | -697.38 |
| 2024-11-13 | -701.11 |
| 2024-11-12 | -739.91 |
| 2024-11-11 | -777.11 |
| 2024-11-08 | -707.48 |
| 2024-11-07 | -739.91 |
| 2024-11-06 | -849.40 |
| 2024-11-05 | -829.73 |
| 2024-11-04 | -789.34 |
| 2024-11-01 | -776.05 |
| 2024-10-31 | -778.71 |
| 2024-10-30 | -802.63 |
| 2024-10-29 | -776.58 |
| 2024-10-28 | -775.52 |
| 2024-10-25 | -742.03 |
| 2024-10-24 | -742.03 |
| 2024-10-23 | -731.93 |
| 2024-10-22 | -740.44 |
| 2024-10-21 | -733.53 |
| 2024-10-18 | -734.06 |
| 2024-10-17 | -738.31 |
| 2024-10-16 | -803.16 |
| 2024-10-15 | -797.31 |
| 2024-10-14 | -792.00 |
| 2024-10-11 | -816.45 |
| 2024-10-10 | -757.45 |
| 2024-10-09 | -764.36 |
| 2024-10-08 | -757.98 |
| 2024-10-07 | -762.76 |
| 2024-10-04 | -761.17 |
| 2024-10-03 | -743.63 |
| 2024-10-02 | -786.15 |
| 2024-10-01 | -795.18 |